The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 21, 2017

Filed:

Nov. 26, 2014
Applicant:

Oncoethix Gmbh, Lausanne, CH;

Inventors:

Maria E. Riveiro, Clichy, FR;

Eric Raymond, Noiseau, FR;

Assignee:

MERCK SHARP & DOHME CORP., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/55 (2006.01); A61K 31/551 (2006.01); A61K 45/06 (2006.01); A61K 9/10 (2006.01); A61K 47/38 (2006.01); A61K 9/16 (2006.01); A61K 9/48 (2006.01); A61K 31/436 (2006.01); A61K 31/4545 (2006.01); A61K 9/00 (2006.01); A61K 9/50 (2006.01);
U.S. Cl.
CPC ...
A61K 31/551 (2013.01); A61K 9/0019 (2013.01); A61K 9/10 (2013.01); A61K 9/1635 (2013.01); A61K 9/1641 (2013.01); A61K 9/1652 (2013.01); A61K 9/4816 (2013.01); A61K 9/4866 (2013.01); A61K 9/5078 (2013.01); A61K 31/436 (2013.01); A61K 31/4545 (2013.01); A61K 45/06 (2013.01); A61K 47/38 (2013.01);
Abstract

A method of treating non-small cell lung cancer in a mammal by administering to a patient a pharmaceutically acceptable amount of a compound being a thienotriazolodiazepine compound of the Formula (1) wherein Ris alkyl having a carbon number of 1-4, Ris a hydrogen atom; a halogen atom; or alkyl having a carbon number of 1-4 optionally substituted by a halogen atom or a hydroxyl group, Ris a halogen atom; phenyl optionally substituted by a halogen atom, alkyl having a carbon number of 1-4, alkoxy having a carbon number of 1-4 or cyano; —NR—(CH)—Rwherein Ris a hydrogen atom or alkyl having a carbon number of 1-4, m is an integer of 0-4, and Ris phenyl or pyridyl optionally substituted by a halogen atom; or —NR—CO—(CH)—Rwherein Ris a hydrogen atom or alkyl having a carbon number of 1-4, n is an integer of 0-2, and Ris phenyl or pyridyl optionally substituted by a halogen atom, and Ris —(CH)—CO—NH—Rwherein a is an integer of 1-4, and Ris alkyl having a carbon number of 1-4; hydroxyalkyl having a carbon number of 1-4; alkoxy having a carbon number of 1-4; or phenyl or pyridyl optionally substituted by alkyl having a carbon number of 1-4, alkoxy having a carbon number of 1-4, amino or a hydroxyl group or —(CH)—COORwherein b is an integer of 1-4, and Ris alkyl having a carbon number of 1-4, or a pharmaceutically acceptable salt thereof or a hydrate or solvate thereof.


Find Patent Forward Citations

Loading…